We are live on ! Find out more
MG

Marex Group Portfolio holdings

AUM $15.8B
1-Year Est. Return 31.44%
This Fund
S&P 500
This Quarter Est. Return
-3.66%
1 Year Est. Return
+31.44%
3 Year Est. Return
+143.62%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.22B
AUM Growth
-$652M
Cap. Flow
-$274M
Cap. Flow %
-5.26%
Top 10 Hldgs %
41.14%
Holding
893
New
216
Increased
212
Reduced
176
Closed
209

Top Buys

Rank Stock Value
1
MSTR icon
Strategy Inc
MSTR
+$227M
2
MA icon
Mastercard
MA
+$147M
3
UNH icon
UnitedHealth
UNH
+$86.2M
4
KLAC icon
KLA
KLAC
+$84.7M
5
LOW icon
Lowe's Companies
LOW
+$73.4M

Top Sells

Rank Stock Value
1
SMCI icon
Super Micro Computer
SMCI
+$264M
2
AVGO icon
Broadcom
AVGO
+$111M
3
NVDA icon
NVIDIA
NVDA
+$103M
4
AAPL icon
Apple
AAPL
+$101M
5
HD icon
Home Depot
HD
+$97.4M

Sector Composition

Rank Sector Weight
1 Technology 31.39%
2 Healthcare 14.48%
3 Consumer Discretionary 14.01%
4 Financials 11.62%
5 Industrials 5.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ECDA
651
DELISTED
ECD Automotive Design
ECDA
$30.8K ﹤0.01%
263
– –
MRDN
652
Meridian Holdings Inc
MRDN
$165M
$30.2K ﹤0.01%
+1,277
New +$31K
ADAG
653
Adagene
ADAG
$219M
$29.9K ﹤0.01%
+19,423
New +$36.3K
ACRV icon
654
Acrivon Therapeutics
ACRV
$69.8M
$28.6K ﹤0.01%
14,080
+893
+7% +$4.81K
AMOD
655
Alpha Modus Holdings
AMOD
$17.8M
$25.1K ﹤0.01%
+487
New +$39.2K
IMUX icon
656
Immunic
IMUX
$190M
$24.5K ﹤0.01%
2,250
– –
PALI icon
657
Palisade Bio
PALI
$341M
$24.3K ﹤0.01%
35,759
– –
HUMA icon
658
Humacyte
HUMA
$173M
$23.6K ﹤0.01%
+13,854
New +$52K
MREO
659
Mereo BioPharma
MREO
$47.1M
$22.5K ﹤0.01%
10,000
– –
ACRS icon
660
Aclaris Therapeutics
ACRS
$746M
$22K ﹤0.01%
14,400
– –
MGX icon
661
Metagenomi Therapeutics
MGX
$45.6M
$20.4K ﹤0.01%
15,000
– –
NCEW
662
New Century Logistics (BVI) Ltd
NCEW
$53.8M
$20.1K ﹤0.01%
+1,525
New +$19.7K
BLNK icon
663
Blink Charging
BLNK
$79M
$19.6K ﹤0.01%
21,408
-71,492
-77% -$82.7K
AUTL
664
Autolus Therapeutics
AUTL
$399M
$19.4K ﹤0.01%
12,500
– –
TSHA icon
665
Taysha Gene Therapies
TSHA
$1.59B
$17.4K ﹤0.01%
12,500
– –
PDSB icon
666
PDS Biotechnology
PDSB
$38.3M
$16.7K ﹤0.01%
14,000
– –
KEEL
667
Keel Infrastructure Corp
KEEL
$2.69B
$15.5K ﹤0.01%
+19,649
New +$26K
EHGO
668
Eshallgo Inc
EHGO
$6.49M
$15.3K ﹤0.01%
+1,000
New +$21.3K
ORGN
669
DELISTED
Origin Materials
ORGN
$13.3K ﹤0.01%
667
– –
CAPTW
670
DELISTED
Captivision Inc Warrant
CAPTW
$10K ﹤0.01%
527,155
– –
WW
671
DELISTED
WW International
WW
$7.78K ﹤0.01%
14,886
-121,000
-89% -$105K
BON
672
Bon Natural Life
BON
$9.27M
$6.66K ﹤0.01%
+2,848
New +$77.8K
RNAZ icon
673
TransCode Therapeutics
RNAZ
$5.89M
$6.28K ﹤0.01%
+453
New +$58K
CHPT icon
674
ChargePoint
CHPT
$136M
$6.14K ﹤0.01%
508
-2,220
-81% -$37K
GNS icon
675
Genius Group
GNS
$32.8M
$5.24K ﹤0.01%
+22,000
New +$9.84K
25 26
27
28 29

Similar funds

CLGM
Capitolis Liquid Global Markets New York $15.7B AUM 30.78% 1-Year Est. Return
LCIP
Life Cycle Investment Partners London $15.7B AUM
EF
Empowered Funds Havertown, Pennsylvania $15.7B AUM 34.02% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return
EH
Equitable Holdings New York $15.5B AUM 19.09% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $15.5B AUM 25.52% 1-Year Est. Return

Marex Group's Q1 2025 Portfolio in Review

As of Q1 2025, Marex Group held 893 positions worth $5.22B, down 11% from $5.87B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Marex Group withdrew a net $274M in Q1 2025, closing 209 positions and reducing 176 holdings. Its most notable exit was Honeywell, an estimated $56.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Marex Group opened a new position in IonQ worth $23.3M.

  • Marex Group's largest Q1 2025 buy was IonQ: 1,054,195 shares worth $23.3M.
  • Marex Group added most to Strategy Inc in Q1 2025, an estimated $227M increase.
  • Marex Group's biggest Q1 2025 reduction was Super Micro Computer, cutting an estimated $264M.
  • Marex Group fully exited Honeywell in Q1 2025, selling an estimated $56.5M.
  • Marex Group's ten largest holdings make up 41% of its $5.22B portfolio in Q1 2025.
  • Marex Group opened 216 new positions and closed 209 in Q1 2025.
  • Marex Group's portfolio value fell 11% quarter-over-quarter to $5.22B.

Based on Marex Group's 13F filing for Q1 2025, filed 2 Apr 2026.